Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach

Aniek J. G. Even*, Olga Hamming-Vrieze, Wouter van Elmpt, Veronique J. L. Winnepenninckx, Jolien Heukelom, Margot E. T. Tesselaar, Wouter V. Vogel, Ann Hoeben, Catharina M. L. Zegers, Danielle J. Vugts, Guus A. M. S. van Dongen, Harry Bartelink, Felix M. Mottaghy, Frank Hoebers, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

49 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach'. Together they form a unique fingerprint.

INIS

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science